Exploring Factors Affecting on the Pharmaceutical Distribution Industry: the Case of Kazakhstan
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This research is aimed to explore factors affecting on Kazakhstan’s pharmaceutical distribution industry, selection of various factors and assessment of the level of their influence. Based on the literature review it was defined that there is a great variety of scientific works relating to pharmaceutical distribution industry competitiveness and management improvement. Research design, data and methodology: There is very little research, which to determine the issues of pharmaceutical industry distribution in developing countries, in particular EAEU countries. The algorithm was chosen for research provision: statistical and comparative analysis, correlation, and regression analysis. The data of 1993-2020 obtained from the World Bank, Bureau of National Statistics, National Bank of Kazakhstan, which is expressed by 19 factors as macroeconomic indicators. Results: The chosen variables were selected nonrandomly, these economic indicators had the most reliable, unique, and utmost for the whole research period complete information. Conclusions: There could be made adequate conclusions of the research, there is a strong positive relationship for six factors: population, GDP per capita, average annual US dollar exchange rate, the minimum pension, average assigned monthly pension, minimum wage. Pension and wage are the most significant factors affecting on the pharmaceutical distribution industry in Kazakhstan.
Abstract
Purpose: This research is aimed to explore factors affecting on Kazakhstan’s pharmaceutical distribution industry, selection of various factors and assessment of the level of their influence. Based on the literature review it was defined that there is a great variety of scientific works relating to pharmaceutical distribution industry competitiveness and management improvement. Research design, data and methodology: There is very little research, which to determine the issues of pharmaceutical industry distribution in developing countries, in particular EAEU countries. The algorithm was chosen for research provision: statistical and comparative analysis, correlation, and regression analysis. The data of 1993-2020 obtained from the World Bank, Bureau of National Statistics, National Bank of Kazakhstan, which is expressed by 19 factors as macroeconomic indicators. Results: The chosen variables were selected nonrandomly, these economic indicators had the most reliable, unique, and utmost for the whole research period complete information. Conclusions: There could be made adequate conclusions of the research, there is a strong positive relationship for six factors: population, GDP per capita, average annual US dollar exchange rate, the minimum pension, average assigned monthly pension, minimum wage. Pension and wage are the most significant factors affecting on the pharmaceutical distribution industry in Kazakhstan.
참고문헌 (38)
- Abha, W., "Evaluating the Effect of Digitalization on the Sales Force of Pharmaceutical Industry", Economics and Applied Informatics, 2, pp.21~29 (2018)[DOI]
- Achuora, J., "Factors Affecting Distribution Performance for Pharmaceutical Products in Kenya's Public Sector", The Journal of Innovations, 7(2), pp.55~61 (2012)[DOI]
- Amran, A., "Sustainability reporting : meeting stakeholder demands", Strategic Direction, 30(7), pp.38~41 (2014)[DOI]
- Anand, V., "Employee Engagement – A Pragmatic Study with Reference to Pharmaceutical Industry, Tamil Nadu", Research Journal of Pharmacy and Technology, 10(6), pp.1583~1588 (2017)[DOI]
- Arnold, R., "Pharmacoeconomics: From Theory to Practice" (2009), CRC Press
- Armstrong, B. K., "Challenges in health and health care for Australia", Medical Journal of Australia, 187(9), pp.485~489 (2007)[DOI]
- "Annual statistical collections of the Republic of Kazakhstan" (2020)[URL]
- Boldeanu, D, "The Analysis of the Influence Factors Affecting the Performance of Pharmaceutical Companies", Theoretical and Applied Economics, 7(596), pp.23~42 (2014)
- Castensson, S., "Pharmaceuticals in the Environment", pp.488~499 (2008), Springer
- Coughlan, M., "Doing a Literature Review in Nursing, Health and Social Care" (2013), SAGE Publications Ltd
- Esmaeillou, Y., "Identifying Factors Affecting the Pharmaceutical Supply Chain Management in Iran", Galen Medical Journal, 6(4), pp.346~355 (2017)[DOI]
- Fidler, A, "Governance in the pharmaceutical sector", EuroHealth, 14(1), pp.25~29 (2008)
- Grabowski, H. G., "The determinants of pharmaceutical research and development expenditures", Journal of Evolutionary Economics, 10(1), pp.201~215 (2000)[DOI]
- Grujić, J., "Analysis of Risk Factors in the Channels of Drug Distribution : Professional Perspectives", Sustainability, 12(11), pp.4787~ (2020)[DOI]
- Harrington, N. G., "Health Communication: Theory, Method, and Application" (2014), Routledge
- Hajli, M. N., "A study of the impact of social media on consumers", International Journal of Market Research, 56(3), pp.387~404 (2014)[DOI]
- Hanson, C. L., "Understanding and Predicting Social Media Use Among Community Health Centre Patients: A CrossSectional Survey", Journal of Medical Internet Research, 16(11), pp.e270~ (2014)[DOI]
- Hristova, S., "Trade-Off Between Liquidity and Profitability : An Empirical Study of Pharmaceutical Sector in the Republic of North Macedonia", Timisoara Journal of Economics and Business, 12(2), pp.127~148 (2019)[DOI]
- Islam, M. N., "The Determinants of Profitability of the Pharmaceutical Industry of Bangladesh : A Random Effect Analysis", International Journal of Financial Research, 10(2), pp.68~74 (2019)[DOI]
- Jaseem, M., "An overview of waste management in pharmaceutical industry", The Pharma Innovation Journal, 6(3), pp.158~161 (2017)
- Jiang, M., "Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of China", PLoS ONE, 8(8), pp.e70836~ (2013)[DOI]
- Kimmel, A. J., "Ethical Issues in Behavioral Research:Basic and Applied Perspectives" (2009), John Wiley & Sons
- 김범년, "The effects of slack resources on firm performance and innovation in the Korean pharmaceutical industry", ASIAN JOURNAL OF TECHNOLOGY INNOVATION, 25(3), pp.387~406 (2017), 기술경영경제학회
- Yong-Ha, KIM, "Determinants of Sustainability Performance in Pharmaceutical Distribution Industry", 유통과학연구, 18(12), pp.91~100 (2020), 한국유통과학회
- 이문재, "Analysis on Time-Lag Effect of Research and Development Investment in the Pharmaceutical Industry in Korea", Osong Public Health and Research Perspectives, 6(4), pp.241~248 (2015), 질병관리본부
- Changjoon LEE, "Impact of Informational Justice on Pharmaceutical Enterprises", 유통과학연구, 18(8), pp.55~64 (2020), 한국유통과학회[DOI]
- Miller, K., "War exposure, daily stressors, and mental health in conflict and post-conflict settings : bridging the divide between trauma-focused and psychosocial frameworks", Social science & medicine, 70(1), pp.7~16 (2010)[DOI]
- Nailya K. NURLANOVA, "Reduction of Economic Disparities in the Regions of Kazakhstan Based on Inclusive Development", The Journal of Asian Finance, Economics and Business, 6(2), pp.299~307 (2019), 한국유통과학회
- Pal, B., "Innovation and business sustainability (IBS): empirical evidence from Indian pharmaceutical industry (IPI)", Artificial Intelligence for Engineering Design, Analysis and Manufacturing, 33(2), pp.117~128 (2019)[DOI]
- Plumb, K., "Continuous processing in the pharmaceutical industry : changing the mind set", Chemical Engineering Research and Design, 83(6), pp.730~738 (2005)[DOI]
- Prajapati, D., "Determination of level of correlation for products of pharmaceutical industry by using modified X-bar chart", International Journal of Quality &Reliability Management, 33(6), pp.724~746 (2016)[DOI]
- "China-EAEU Trade Share Increases By 20% In 2020" (2020)[URL]
- Shabaninejad, H., "Identifying and prioritizing industrylevel competitiveness factors : evidence from pharmaceutical market", DARU Journal of Pharmaceutical Sciences, 22(35), pp.35~45 (2013)[DOI]
- Sheldon, R., "Chirotechnology: Industrial Synthesis of Optically Active Compounds" (1993), CRC Press
- Tyagi, S., "Firm level profitability determinants in Indian drugs and pharmaceutical industry", International Journal of Pharmaceutical and Healthcare Marketing, 11(3), pp.271~290 (2017)[DOI]
- Yong, T. M., "Determinants of dividend payout ratio : evidence from Malaysian public listed firms", Journal of Applied Environmental and Biological Sciences, 6(15), pp.48~54 (2016)[DOI]
- Vaz, K. V, "Investigação sobre a forma de descarte de medicamentos vencidos", Cenarium Pharmacêutico, 4(4), pp.3~27 (2011)
- Wernet, G, "Life cycle assessment of fine chemical production: a case study of pharmaceutical synthesis", The International Journal of Life Cycle Assessment, 15(3), pp.294~303 (2010)[DOI]